President Donald Trump said the U.S. has struck Iranian nuclear sites, escalating the Israel-Iran conflict. Retired U.S. Army Col. Jack Jacobs explains the strategic impact of the attack and what Iran might do next. CNBC’s Emily Wilkins covers the reaction in Washington and gives an update on President Trump’s Big Beautiful Bill. Then, Gilead Sciences CEO Daniel O’Day talks about the FDA approval of Yeztugo, a twice-yearly HIV prevention drug, and its importance in public health. Plus, Pixar’s Elio sees the worst box office opening in the studio’s history. Col. Jack Jacobs - 05:06Emily Wilkins - 17:39Daniel O'Day - 24:20 In this episode:Emily Wilkins, @emrwilkinsBecky Quick, @BeckyQuickJoe Kernen, @JoeSquawkAndrew Ross Sorkin, @andrewrsorkinZach Vallese, @zachvallese Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ver todos los episodios